The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

In the Effaclar A.Z. Gel-Cream, not only are you getting 10% azelaic acid, but you're also getting your faves, salicylic acid ...

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...

Delgocitinib is a JAK inhibitor that blocks the activation of the JAK-STAT pathway which has been shown to play a key role in the pathophysiology of chronic inflammatory skin diseases.

The FDA has approved a new treatment, sold under the name Anzupgo and containing a drug called delgocitinib, as the first skin cream for adults with long-term or chronic hand eczema (CHE), which ...

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...

Amazon. This overnight face cream contains an impressive blend of nourishing ingredients formulated to renew your complexion. It taps the deeply moisturizing propertie ...

The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA. The agency approved delgocitinib cream 2% (Anzupgo) for adults with moderate-to-severe CHE, ...